Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 789325, 7 pages
http://dx.doi.org/10.1155/2012/789325
Clinical Study

Stepwise Increases in Left Ventricular Mass Index and Decreases in Left Ventricular Ejection Fraction Correspond with the Stages of Chronic Kidney Disease in Diabetes Patients

1Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung 812, Taiwan
3Department of Renal Care, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
4Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
5Department of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan

Received 9 May 2011; Accepted 24 June 2011

Academic Editor: Yingmei Zhang

Copyright © 2012 Szu-Chia Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ritz, “Diabetic nephropathy,” Saudi Journal of Kidney Diseases and Transplantation, vol. 17, no. 4, pp. 481–490, 2006. View at Google Scholar · View at Scopus
  2. E. Ritz, “Heart and kidney: fatal twins?” American Journal of Medicine, vol. 119, supplement 1, no. 5, pp. S31–S39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Levin, J. Singer, C. R. Thompson, H. Ross, and M. Lewis, “Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention,” American Journal of Kidney Diseases, vol. 27, no. 3, pp. 347–354, 1996. View at Google Scholar · View at Scopus
  4. A. Levin, C. R. Thompson, J. Ethie et al., “Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin,” American Journal of Kidney Diseases, vol. 34, no. 1, pp. 125–134, 1999. View at Google Scholar · View at Scopus
  5. A. Veves, C. M. Akbari, J. Primavera et al., “Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration,” Diabetes, vol. 47, no. 3, pp. 457–463, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Glowinska, J. Grochowski, and J. Malyszko, “Cardiovascular complications in patients with diabetic nephropathy receiving pharmacological versus renal replacement therapy,” Polskie Archiwum Medycyny Wewnętrznej, vol. 118, no. 7-8, pp. 404–412, 2008. View at Google Scholar
  7. A. Mataradzija, H. Resic, S. Rasic, N. Kukavica, and F. Masnic, “Risk factors for development of cardiovascular complications in patients with chronic renal disease and diabetic nephropathy,” Bosnian Journal of Basic Medical Sciences, vol. 10, supplement 1, pp. S44–S50, 2010. View at Google Scholar
  8. K. U. Eckardt, A. Scherhag, I. C. Macdougall et al., “Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD,” Journal of the American Society of Nephrology, vol. 20, no. 12, pp. 2651–2660, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Silaruks, D. Sirivongs, and D. Chunlertrith, “Left ventricular hypertrophy and clinical outcome in CAPD patients,” Peritoneal Dialysis International, vol. 20, no. 4, pp. 461–466, 2000. View at Google Scholar · View at Scopus
  10. A. S. Levey, J. Coresh, K. Bolton et al., “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, supplement 1, no. 2, pp. S1–S266, 2002. View at Google Scholar · View at Scopus
  11. R. B. Devereux, D. R. Alonso, and E. M. Lutas, “Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings,” American Journal of Cardiology, vol. 57, no. 6, pp. 450–458, 1986. View at Google Scholar · View at Scopus
  12. R. B. Devereux, “Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods,” Hypertension, vol. 9, no. 2, pp. II19–II26, 1987. View at Google Scholar · View at Scopus
  13. S. Vickery, P. E. Stevens, R. N. Dalton, F. van Lente, and E. J. Lamb, “Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays?” Nephrology Dialysis Transplantation, vol. 21, no. 9, pp. 2439–2445, 2006. View at Publisher · View at Google Scholar
  14. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar
  15. E. Paoletti, D. Bellino, P. Cassottana, D. Rolla, and G. Cannella, “Left ventricular hypertrophy in nondiabetic predialysis CKD,” American Journal of Kidney Diseases, vol. 46, no. 2, pp. 320–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. G. A. Stewart, R. T. Gansevoort, P. B. Mark et al., “Electrocardiographic abnormalities and uremic cardiomyopathy,” Kidney International, vol. 67, no. 1, pp. 217–226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Zoccali, “How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease?” Nature Clinical Practice Nephrology, vol. 3, no. 4, pp. 178–179, 2007. View at Google Scholar
  18. J. D. Harnett, P. S. Parfrey, S. M. Griffiths, M. H. Gault, P. Barre, and R. D. Guttmann, “Left ventricular hypertrophy in end-stage renal disease,” Nephron, vol. 48, no. 2, pp. 107–115, 1988. View at Google Scholar · View at Scopus
  19. J. D. A. Barrionuevo, M. F. G. Vargas-Machuca, F. G. Pulido, L. G. Sacaluga, M. A. G. Govantes, and A. Martinez-Martinez, “Transthoracic echocardiographic findings in patients with chronic kidney disease awaiting kidney transplantation,” Transplantation Proceedings, vol. 42, no. 8, pp. 3123–3125, 2010. View at Publisher · View at Google Scholar
  20. J. J. Olivero and P. T. Nguyen, “Chronic kidney disease: a marker of cardiovascular disease,” Methodist DeBakey Cardiovascular Journal, vol. 5, no. 2, pp. 24–29, 2009. View at Google Scholar · View at Scopus
  21. B. Rodriguez-Iturbe and R. Correa-Rotter, “Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease,” Expert Opinion on Pharmacotherapy, vol. 11, no. 16, pp. 2687–2698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Zoccali, F. A. Benedetto, G. Tripepi et al., “Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study,” Journal of the American Society of Nephrology, vol. 17, no. 5, pp. 1460–1465, 2006. View at Publisher · View at Google Scholar
  23. J. S. Silberberg, P. E. Barre, S. S. Prichard, and S. D. Sniderman, “Impact of left ventricular hypertrophy on survival in end-stage renal disease,” Kidney International, vol. 36, no. 2, pp. 286–290, 1989. View at Google Scholar · View at Scopus
  24. G. Cintron, G. Johnson, G. Francis, F. Cobb, and J. N. Cohn, “Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA cooperative studies group,” Circulation, vol. 87, supplement 6, pp. VI17–VI23, 1993. View at Google Scholar
  25. S. Kursat, H. Tekce, C. Ekmekci, H. B. Colak, and T. Alici, “Relationship between the degree of malnutrition and echocardiographic parameters in hemodialysis patients,” Nephron Clinical Practice, vol. 106, no. 3, pp. c136–c142, 2007. View at Publisher · View at Google Scholar
  26. H. L. Hillege, A. R. Girbes, P. J. de Kam et al., “Renal function, neurohormonal activation, and survival in patients with chronic heart failure,” Circulation, vol. 102, no. 2, pp. 203–210, 2000. View at Google Scholar · View at Scopus
  27. N. W. Levin, G. J. Handelman, J. Coresh, F. K. Port, and G. A. Kaysen, “Reverse epidemiology: a confusing, confounding, and inaccurate term,” Seminars in Dialysis, vol. 20, no. 6, pp. 586–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Io, M. Matsumoto, K. Okumura et al., “Predictive factors associated with left ventricular hypertrophy at baseline and in the follow-up period in non-diabetic hemodialysis patients,” Seminars in Dialysis, vol. 24, no. 3, pp. 349–354, 2011. View at Publisher · View at Google Scholar
  29. G. M. Trovato, E. Iannetti, D. Catalano, R. Squatrito, M. Vitale, and G. Zuccala, “[Heart failure and nutritional status in hemodialysis],” Recenti Progressi in Medicina, vol. 92, no. 11, pp. 655–659, 2001. View at Google Scholar